Featured News
Introducing the Apollo™ Price Estimator
New tool generates instant price estimate and lead-in times for oncology studies
In April 2024, we launched the Apollo™ Price Estimator to help oncology researchers save time, provide scientific guidance, and give them more control over their budget.
In this easy-to-use online tool, you can see how different options and customizations impact your budget. Choose between elements such as PDX, CDX, and syngeneic models in addition to compounds, dosing, groups, and sampling along with downstream analytics. You then have the option to download a PDF copy and/or have the information sent to our team.
Scientific guidance is built in so you can design your study on your own or with the advice of our team. If you still need assistance, oncology experts are available to quickly answer your questions for the design and purchase of PDX, CDX, and syngeneic model studies.
We debuted the Apollo Price Estimator at the American Association of Cancer Research (AACR) and heard the following from oncology researchers:
“With 15 concurrent studies, this software plays a crucial role in managing our timelines and expediting the progress of our projects.” Pharmacology Team Lead, Biotech
“This saves our team a lot of time; we get an idea of pricing without any back-and-forth communication.” Research Sciences Project Manager, Pharma
“This is an invaluable tool to my team as it allows us to quickly get a price estimate so we can be prepared for budgetary planning meetings, as well as keeping on top of our existing estimates.” Pharmacology Team Lead, Biotech